UPDATE: Abbott Announces Purchase of CFR Pharma, Purchase Price Will Be $2.9B Plus $430M in Assumed Debt
May 16, 2014 at 07:31 AM EDT
Abbott (NYSE: ABT) today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more ...
